For the year ending 2025-12-31, MDGL has $1,259,589K in assets. $656,900K in debts. $198,693K in cash and cash equivalents.
| Balance Sheets | 2025-12-31 | |||
|---|---|---|---|---|
| Cash and cash equivalents | 198,693 | |||
| Restricted cash | 5,090 | |||
| Marketable securities | 784,866 | |||
| Trade receivables, net | 134,476 | |||
| Inventory | 74,841 | |||
| Prepaid expenses and other current assets | 47,804 | |||
| Total current assets | 1,245,770 | |||
| Property and equipment, net | 1,499 | |||
| Intangible assets, net | 7,381 | |||
| Right-of-use asset | 4,939 | |||
| Total assets | 1,259,589 | |||
| Accounts payable | 48,878 | |||
| Accrued liabilities | 260,392 | |||
| Lease liabilities | 1,018 | |||
| Total current liabilities | 310,288 | |||
| Loan payable, net of discount | 339,881 | |||
| Lease liabilities | 6,731 | |||
| Total long term liabilities | 346,612 | |||
| Total liabilities | 656,900 | |||
| Common stock, par value 0.0001 per share authorized 200,000,000 at december31, 2025 and december31, 2024 22,842,073 and 22,004,679 shares issued and outstanding at december31, 2025 and december31, 2024, respectively | 2 | |||
| Additional paid-in-capital | 2,692,280 | |||
| Accumulated other comprehensive income | 873 | |||
| Accumulated deficit | -2,090,466 | |||
| Total stockholders equity | 602,689 | |||
| Total liabilities and stockholders equity | 1,259,589 | |||
MADRIGAL PHARMACEUTICALS, INC. (MDGL)
MADRIGAL PHARMACEUTICALS, INC. (MDGL)